SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Procept (PRCT): 50% rise on high volume. Why?
PRCT 30.42-1.1%Nov 13 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: James Silverman who wrote (54)2/18/1997 10:17:00 AM
From: Gerald Thomas   of 455
 
I don't know if the aids gel is a complete waste of money or not...

The entire thing hinges on wheter or not the active ingredient PRO -2000 works or not..

It just amazes me that all of the companies info says the systemic
trial will be completed in the fourth quarter of 1996 and 6 weeks later
no word on anything...

There are several ways to look at this:
1) If the trial was going badly ,why keep it going....
2) If the trial was going badly why start 2 other trials based on the same ingredient..
3)My thinking all along is that IF this is going well in the systemic trial(and they would have to know) are they trying to reach a
specific conclusion ie. that resistance does or does not occur after
a certain period...
4) they probably would be well served to release preliminary conclusions to boost their market cap...But possibly they aren't that smart or don't care..
I agree that cash could become a problem but I'm not sure if it will short term...
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext